The Oncologist http://theoncologist.alphamedpress.org/subscriptions/etoc.dtl
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

    Volume 10, Number 6, 2005   [Index by author] 

      Down FDA COMMENTARIES
      Down ORIGINAL PAPERS
             Down BREAST CANCER
             Down CLINICAL PHARMACOLOGY
             Down HEPATOBILIARY
             Down LUNG CANCER
             Down LYMPHOMA
             Down SYMPTOM MANAGEMENT AND SUPPORTIVE CARE
      Down SCHWARTZ CENTER ROUNDS
      Down LETTERS TO THE EDITOR
      Down REFLECTIONS

Cover Image
Other Issues:
Previous Next
Find articles in this issue containing these words:
[Search ALL Issues]

Receive this page by email each issue: [Sign up for eTOCs]
To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.



Back   FDA COMMENTARIES

FDA Drug Approval Summary: Pemetrexed for Injection (Alimta®) for the Treatment of Non-Small Cell Lung Cancer
Martin H. Cohen, John R. Johnson, Yong-Cheng Wang, Rajeshwari Sridhara, Richard Pazdur
The Oncologist 2005; 10: 363-368; doi:10.1634/theoncologist.10-6-363
[Abstract] [Full Text] [PDF] CME  

Back   ORIGINAL PAPERS

Back   BREAST CANCER
Breast Cancer: A Tale of Two Centuries: With Implications for Understanding Cancer Metastasis and Cancer Stem Cell Biology
Bruce A. Chabner, Martin J. Murphy, Jr.
The Oncologist 2005; 10: 369; doi:10.1634/theoncologist.10-6-369
[Full Text] [PDF]  
Conceptual and Practical Implications of Breast Tissue Geometry: Toward a More Effective, Less Toxic Therapy
Larry Norton
The Oncologist 2005; 10: 370-381; doi:10.1634/theoncologist.10-6-370
[Abstract] [Full Text] [PDF] [Supplemental DVD] CME  

Back   CLINICAL PHARMACOLOGY
VEGF-Targeted Therapy: Therapeutic Potential and Recent Advances
Lee S. Rosen
The Oncologist 2005; 10: 382-391; doi:10.1634/theoncologist.10-6-382
[Abstract] [Full Text] [PDF] CME  

Back   HEPATOBILIARY
A Phase II Study of Epirubicin and Thalidomide in Unresectable or Metastatic Hepatocellular Carcinoma
Andrew X. Zhu, Charles S. Fuchs, Jeffrey W. Clark, Alona Muzikansky, Kerry Taylor, Susan Sheehan, Kayao Tam, Elizabeth Yung, Matthew H. Kulke, David P. Ryan
The Oncologist 2005; 10: 392-398; doi:10.1634/theoncologist.10-6-392
[Abstract] [Full Text] [PDF]  

Back   LUNG CANCER
Treatment of Small Cell Lung Cancer in the Elderly
Antonio Rossi, Paolo Maione, Giuseppe Colantuoni, Ciro Guerriero, Carmine Ferrara, Filomena Del Gaizo, Dario Nicolella, Cesare Gridelli
The Oncologist 2005; 10: 399-411; doi:10.1634/theoncologist.10-6-399
[Abstract] [Full Text] [PDF]  

Back   LYMPHOMA
AIDS-Related Malignancies: Emerging Challenges in the Era of Highly Active Antiretroviral Therapy
Matthew C. Cheung, Liron Pantanowitz, Bruce J. Dezube
The Oncologist 2005; 10: 412-426; doi:10.1634/theoncologist.10-6-412
[Abstract] [Full Text] [PDF] CME  

Back   SYMPTOM MANAGEMENT AND SUPPORTIVE CARE
Risk Models for Predicting Chemotherapy-Induced Neutropenia
Gary H. Lyman, Christopher H. Lyman, Olayemi Agboola, for the Anc Study Group
The Oncologist 2005; 10: 427-437; doi:10.1634/theoncologist.10-6-427
[Abstract] [Full Text] [PDF]  
Assessing the Clinical Benefits of Erythropoietic Agents Using Area Under the Hemoglobin Change Curve
Mei Sheng Duh, Patrick Lefebvre, John Fastenau, Catherine Tak Piech, Roger J. Waltzman
The Oncologist 2005; 10: 438-448; doi:10.1634/theoncologist.10-6-438
[Abstract] [Full Text] [PDF]  

Back   SCHWARTZ CENTER ROUNDS
Learning to Cope: How Far Is Too Close?
Brian M. Wolpin, Bruce A. Chabner, Thomas J. Lynch, Jr., Richard T. Penson
The Oncologist 2005; 10: 449-456; doi:10.1634/theoncologist.10-6-449
[Abstract] [Full Text] [PDF] CME  

Back   LETTERS TO THE EDITOR
Development of Multiple Myeloma in a Patient with Chronic Myeloid Leukemia After Treatment with Imatinib Mesylate
Vassilia Garipidou, Sofia Vakalopoulou, Konstantinos Tziomalos
The Oncologist 2005; 10: 457-458; doi:10.1634/theoncologist.10-6-457
[Full Text] [PDF]  

Back   REFLECTIONS
Poetry
Sandra Evans Falconer
The Oncologist 2005; 10: 459-460; doi:10.1634/theoncologist.10-6-459
[Full Text] [PDF]  
Reflections
Arthur Skarin
The Oncologist 2005; 10: 460; doi:10.1634/theoncologist.10-6-460
[Full Text] [PDF]  


To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.

Cover Illustration:Back

Cover

Oriental Poppy by Bernique Longley.

Laudanum, or tincture of opium, was for many decades the only "treatment" for cancer in the Old West; the Oriental Poppy has, therefore, been chosen as the journal's icon.


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS
http://theoncologist.alphamedpress.org/misc/eLetters.shtml

Copyright © 2006 by AlphaMed Press.